John Cade, DPM
Podiatrist · Las Vegas, NVNPI 1912096157
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,453 of the $6,494 with a category attached, or 68.6%. 36 manufacturers reported payments, led by Goode Surgical Inc at 28.2% of the total. Reporting peaked in 2019 at $2,046 and has fallen 80.0% since, to $409 in 2025.
Across 196 payments — averaging $33.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$2K
- Treace Medical Concepts, Inc.$1K
- Smith+Nephew$394
- Paratek Pharmaceuticals, Inc.$308
- AbbVie$263
- Integra Lifesciences Corporation$245
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$120%
- Food & beverage$4,45369%
- Education$1,78327%
- Other$2454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 5 | $1,828 |
| Treace Medical Concepts, Inc. | 43 | $1,474 |
| Smith+Nephew | 30 | $394 |
| Paratek Pharmaceuticals, Inc. | 11 | $308 |
| AbbVie(2 entities) | 20 | $263 |
| Integra Lifesciences Corporation | 1 | $245 |
| GSK | 11 | $208 |
| Stryker(2 entities) | 6 | $154 |
| Alfasigma USA, Inc. | 4 | $147 |
| Nevro Corp. | 5 | $136 |
| Amgen(2 entities) | 6 | $135 |
| Tactile Systems Technology Inc | 8 | $132 |
| Heron Therapeutics, Inc. | 1 | $122 |
| In2bones USA, LLC | 1 | $120 |
| Bioventus LLC | 6 | $114 |
| ANI Pharmaceuticals, Inc. | 3 | $61 |
| Abbott | 3 | $58 |
| Kerecis Limited | 2 | $55 |
| Misonix Inc | 3 | $55 |
| Organogenesis Inc. | 2 | $42 |
| Orthofix Medical, Inc. | 4 | $41 |
| Curonix LLC | 2 | $39 |
| Medtronic(2 entities) | 2 | $36 |
| Aroa Biosurgery Incorporated | 1 | $35 |
| Acera Surgical, Inc. | 2 | $34 |
| Forte Bio-pharma LLC | 1 | $32 |
| Stimwave Technologies Incorporated | 4 | $31 |
| Carbofix Orthopedics Inc | 1 | $27 |
| Solventum Corporation | 1 | $27 |
| IBSA Pharma Inc. | 1 | $25 |
| Zimmer Biomet | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Koya Medical, Inc. | 1 | $22 |
| GRT US Holding, Inc. | 1 | $20 |
| Paragon 28, Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$382
- ACell$245
- Zynrelef$122
- CoLink$120
- NUZYRA$116
How this compares
$6,494 in reported general payments places this provider in the 80th percentile of 44 podiatrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 23 | $783 |
| Pregabalin | 19 | $645 |
| Gabapentin | 31 | $372 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $253 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $212 |
| Doxycycline Hyclate | 17 | $180 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $135 |
| Diclofenac Sodium | 11 | $79 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $73 |
| Meloxicam | 32 | $53 |
| Azithromycin | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Las Vegas
- Anthony RicciardiLas Vegas$498K
- Jeremy AndersonLas Vegas$72K
- He XuLas Vegas$54K
- Peter BregmanLas Vegas$18K
- Anmy VuLas Vegas$15K
- Ai Quoc HellerLas Vegas$8K
- Ada VeraLas Vegas$5K
- Michael ChildsLas Vegas$4K
- Justin ColarcoLas Vegas$2K
- Sofia HossainLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.